Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Novo Nordisk has ended its partnership with Hims & Hers, citing concerns over the telehealth company’s promotion and sale of the drugmaker’s compounded versions of Wegovy. The drugmaker alleged that ...

Last month, the two announced a partnership that would enable Wegovy to be directly purchased by patients via Hims’ ...